- Home
- HONE vs ZBIO Comparison
HONE vs ZBIO Comparison
Compare HONE & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HONE
- ZBIO
- Stock Information
- Founded
- HONE 1917
- ZBIO 2019
- Country
- HONE United States
- ZBIO United States
- Employees
- HONE N/A
- ZBIO N/A
- Industry
- HONE Major Banks
- ZBIO
- Sector
- HONE Finance
- ZBIO
- Exchange
- HONE Nasdaq
- ZBIO NYSE
- Market Cap
- HONE 461.5M
- ZBIO 389.2M
- IPO Year
- HONE 2016
- ZBIO 2024
- Fundamental
- Price
- HONE $9.38
- ZBIO $8.92
- Analyst Decision
- HONE Hold
- ZBIO Strong Buy
- Analyst Count
- HONE 1
- ZBIO 7
- Target Price
- HONE $13.00
- ZBIO $32.29
- AVG Volume (30 Days)
- HONE 245.8K
- ZBIO 260.9K
- Earning Date
- HONE 04-28-2025
- ZBIO 05-16-2025
- Dividend Yield
- HONE 3.84%
- ZBIO N/A
- EPS Growth
- HONE 78.38
- ZBIO N/A
- EPS
- HONE 0.66
- ZBIO N/A
- Revenue
- HONE $164,292,000.00
- ZBIO $5,000,000.00
- Revenue This Year
- HONE N/A
- ZBIO N/A
- Revenue Next Year
- HONE $9.42
- ZBIO N/A
- P/E Ratio
- HONE $14.21
- ZBIO N/A
- Revenue Growth
- HONE 0.52
- ZBIO N/A
- 52 Week Low
- HONE $8.89
- ZBIO $5.83
- 52 Week High
- HONE $14.00
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- HONE 36.04
- ZBIO N/A
- Support Level
- HONE $8.89
- ZBIO N/A
- Resistance Level
- HONE $9.50
- ZBIO N/A
- Average True Range (ATR)
- HONE 0.42
- ZBIO 0.00
- MACD
- HONE -0.02
- ZBIO 0.00
- Stochastic Oscillator
- HONE 28.65
- ZBIO 0.00
About HONE HarborOne Bancorp Inc.
HarborOne Bancorp Inc is a bank holding company. The company is engaged in providing financial services like accepting deposits, lending loans, online and mobile banking, cash management, credit cards, money market accounts, and wealth management. The Company has two reportable segments: HarborOne Bank and HarborOne Mortgage. The bank provides financial services to individuals and businesses online and through its full-service branches located in Massachusetts and Rhode Island, one limited-service branch, and a commercial lending office in Boston, Massachusetts, and Providence, Rhode Island.
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.